486 filings
Page 3 of 25
EFFECT
jft0fny0o g2p
12 Jun 23
Notice of effectiveness
12:15am
EFFECT
hx7cb7m0dozehkxycu
12 Jun 23
Notice of effectiveness
12:15am
424B3
eampjrf9
9 Jun 23
Prospectus supplement
4:36pm
424B3
gcziiwd0ep 77rg5k
9 Jun 23
Prospectus supplement
4:35pm
CORRESP
hanhxrcnnikflbj
9 Jun 23
Correspondence with SEC
12:00am
CORRESP
0xhf8 2gzw
9 Jun 23
Correspondence with SEC
12:00am
UPLOAD
3pg8hxj v8940
8 Jun 23
Letter from SEC
12:00am
UPLOAD
pm4u0 s5v63p4p
8 Jun 23
Letter from SEC
12:00am
F-3
jkcg5eh1eaam5
1 Jun 23
Shelf registration (foreign)
4:35pm
F-1
bg36l
1 Jun 23
Registration statement (foreign)
4:31pm
6-K
g29qirj33wko0k9wxuxe
30 May 23
Notice of the Annual General Meeting of Shareholders
8:00am
6-K
718wj bjxgp
26 May 23
Report of Foreign Private Issuer
5:29pm
6-K
1x8q1p
16 May 23
Altamira Therapeutics Provides Business Update, Reports FY 2022 Financial Results
4:30pm
6-K
xjwi h2vdr0jnoh
2 May 23
Convertible Loan Agreement
8:30am
NT 20-F
x2pfvgfw
1 May 23
Notice of late annual filing (foreign)
4:59pm
SC 13D/A
exv2vq1
27 Apr 23
Altamira Therapeutics / Meyer Thomas ownership change
4:30pm
6-K
sj1 tfxxxpx
18 Apr 23
Report of Foreign Private Issuer
8:00am
CERT
dy0ygrkb1a8m7
17 Apr 23
Certification of approval for exchange listing
12:21pm
6-K
m638ki
13 Apr 23
Report of Foreign Private Issuer
9:05am